1. Home
  2. NRXP vs HKIT Comparison

NRXP vs HKIT Comparison

Compare NRXP & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HKIT
  • Stock Information
  • Founded
  • NRXP 2015
  • HKIT 1996
  • Country
  • NRXP United States
  • HKIT China
  • Employees
  • NRXP N/A
  • HKIT N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • NRXP Health Care
  • HKIT Technology
  • Exchange
  • NRXP Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • NRXP 32.6M
  • HKIT 35.7M
  • IPO Year
  • NRXP N/A
  • HKIT 2023
  • Fundamental
  • Price
  • NRXP $2.09
  • HKIT $1.25
  • Analyst Decision
  • NRXP Strong Buy
  • HKIT
  • Analyst Count
  • NRXP 4
  • HKIT 0
  • Target Price
  • NRXP $28.25
  • HKIT N/A
  • AVG Volume (30 Days)
  • NRXP 124.9K
  • HKIT 13.4K
  • Earning Date
  • NRXP 05-13-2025
  • HKIT 05-06-2025
  • Dividend Yield
  • NRXP N/A
  • HKIT N/A
  • EPS Growth
  • NRXP N/A
  • HKIT N/A
  • EPS
  • NRXP N/A
  • HKIT N/A
  • Revenue
  • NRXP N/A
  • HKIT $2,904,950.00
  • Revenue This Year
  • NRXP N/A
  • HKIT N/A
  • Revenue Next Year
  • NRXP N/A
  • HKIT N/A
  • P/E Ratio
  • NRXP N/A
  • HKIT N/A
  • Revenue Growth
  • NRXP N/A
  • HKIT N/A
  • 52 Week Low
  • NRXP $1.10
  • HKIT $1.15
  • 52 Week High
  • NRXP $6.01
  • HKIT $2.18
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.92
  • HKIT 51.31
  • Support Level
  • NRXP $1.85
  • HKIT $1.18
  • Resistance Level
  • NRXP $2.10
  • HKIT $1.27
  • Average True Range (ATR)
  • NRXP 0.16
  • HKIT 0.04
  • MACD
  • NRXP 0.04
  • HKIT 0.01
  • Stochastic Oscillator
  • NRXP 90.18
  • HKIT 77.87

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: